Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC trimmed its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 51.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,853 shares of the real estate investment trust’s stock after selling 31,589 shares during the period. Intech Investment Management LLC’s holdings in Omega Healthcare Investors were worth $1,215,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of OHI. Advisors Asset Management Inc. boosted its stake in shares of Omega Healthcare Investors by 2.6% in the third quarter. Advisors Asset Management Inc. now owns 118,273 shares of the real estate investment trust’s stock worth $4,814,000 after acquiring an additional 3,041 shares during the last quarter. Pathstone Holdings LLC boosted its stake in Omega Healthcare Investors by 23.9% during the 3rd quarter. Pathstone Holdings LLC now owns 32,112 shares of the real estate investment trust’s stock worth $1,307,000 after purchasing an additional 6,199 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of Omega Healthcare Investors during the third quarter worth $514,000. Thrivent Financial for Lutherans raised its position in shares of Omega Healthcare Investors by 1.5% in the third quarter. Thrivent Financial for Lutherans now owns 60,575 shares of the real estate investment trust’s stock valued at $2,465,000 after buying an additional 871 shares during the last quarter. Finally, GoalVest Advisory LLC lifted its stake in shares of Omega Healthcare Investors by 3.0% in the third quarter. GoalVest Advisory LLC now owns 34,214 shares of the real estate investment trust’s stock worth $1,393,000 after buying an additional 993 shares in the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on OHI shares. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Scotiabank increased their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Truist Financial raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, BMO Capital Markets boosted their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has a consensus rating of “Hold” and an average target price of $40.00.

Insider Activity at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Omega Healthcare Investors Trading Up 1.7 %

NYSE OHI opened at $40.77 on Wednesday. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The stock has a market capitalization of $11.01 billion, a P/E ratio of 29.98, a PEG ratio of 1.25 and a beta of 0.99. The firm’s 50-day moving average is $40.61 and its two-hundred day moving average is $37.19. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.57%. Omega Healthcare Investors’s payout ratio is currently 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.